From: Recent incidence trend of elderly patients with glioblastoma in the United States, 2000–2017
Characteristics | Period | APC (95% CI) | P |
---|---|---|---|
Overall | 2000–2017 | 0.3 (−0.1, 0.7) | 0.111 |
Gender | |||
Male | 2000–2017 | 0.2 (− 0.2, 0.6) | 0.272 |
Female | 2000–2017 | 0.2 (− 0.4, 0.8) | 0.402 |
Race | |||
Non-Hispanic White | 2000–2017 | 0.6 (0.2, 1.1) | 0.013c |
Non-Hispanic Black | 2000–2017 | 0.2 (−0.8, 1.3) | 0.648 |
Hispanic | 2000–2017 | 0.0 (−0.9, 0.8) | 0.923 |
API | 2001–2017 | 0.7 (−0.6, 1.9) | 0.266 |
Age at diagnosis, years | |||
65–69 | 2000–2017 | 0.3 (−0.2, 0.8) | 0.219 |
70–74 | 2000–2017 | 0.0 (−0.6, 0.6) | 0.976 |
75–79 | 2000–2017 | 0.3 (−0.5, 1.0) | 0.482 |
80–84 | 2000–2017 | 0.8 (−0.1, 1.7) | 0.092 |
≥85 | 2000–2017 | 0.6 (−0.3, 1.4) | 0.186 |
Histologic type | |||
Glioblastoma, NOS | 2000–2017 | 0.3 (−0.1, 0.7) | 0.107 |
Giant cell glioblastoma | 2000–2017 | −2.3 (−6.1, 1.7) | 0.239 |
Gliosarcoma | 2000–2017 | 1.2 (−1.0, 3.4) | 0.264 |
Tumor location | |||
Supratentorial | 2000–2017 | 0.7 (0.2, 1.3) | 0.016c |
Supratentoriala | 2000–2004 | 5.1 (0.3, 10.2) | 0.039c |
Supratentoriala | 2004–2017 | 0.0 (−0.6, 0.7) | 0.899 |
Frontal | 2000–2017 | 1.7 (1.0, 2.5) | < 0.001c |
Temporal | 2000–2017 | 0.9 (0.3, 1.6) | 0.010c |
Parietal | 2000–2017 | −0.7 (−1.3, 0.0) | 0.060 |
Occipital | 2000–2017 | −0.4 (−1.7, 0.9) | 0.494 |
Infratentorial | 2000–2017 | −0.4 (−3.3, 2.5) | 0.750 |
Overlapping/NOS | 2000–2017 | −0.9 (−1.6, − 0.2) | 0.012c |
Tumor size, cmb | |||
< 4 | 2004–2015 | 2.5 (1.4, 3.6) | < 0.001c |
≥4 | 2004–2015 | 0.8 (0.0, 1.6) | 0.057 |
Unknown | 2004–2015 | −4.9 (−6.6, −3.3) | < 0.001c |